Home › Funds › Burkehill Global Management, LP › COGT
Burkehill Global Management, LP position in COGT
COGENT BIOSCIENCES INC · Health Care
Burkehill Global Management, LP reported holding 325,000 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$10.4M, representing 0.45% of its reported portfolio and ranking #32 among its reported holdings. Burkehill Global Management, LP has disclosed COGT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Burkehill Global Management, LP's COGT position evolved
Burkehill Global Management, LP first disclosed a stake in COGT in Q3 2025 at 200,000 shares (US$2.9M). The position peaked in Q1 2026 at 675,000 shares, worth US$26.0M. Across 5 filings, Burkehill Global Management, LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 325,000 shares valued at US$10.4M. Notable position changes include a 62% increase in Q4 2025 (shares rose 8% over the following quarter), a 108% increase in Q1 2026 (shares were roughly flat over the following quarter), a 52% trim in Q2 2026 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 200.00K | $2.87M | New |
| Q4 2025 | 325.00K | $11.54M | Add |
| Q1 2026 | 675.00K | $25.98M | Add |
| Q2 2026 | 325.00K | $12.58M | Reduce |
| Q3 2026 | 325.00K | $10.41M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COGT and 13F data
COGT (COGENT BIOSCIENCES INC) is a Health Care company. 51 other funds we track also report a position in COGT — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$190.7M), Fairmount Funds Management LLC (US$176.2M), Kynam Capital Management, LP (US$121.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.96M sh · $190.74M · Q3 2026
- Fairmount Funds Management LLC 5.50M sh · $176.22M · Q3 2026
- Kynam Capital Management, LP 3.79M sh · $121.43M · Q3 2026
- TCG Crossover Management, LLC 2.50M sh · $80.05M · Q3 2026
- Deep Track Capital, LP 2.50M sh · $80.05M · Q3 2026
- Octagon Capital Advisors LP 2.35M sh · $75.25M · Q3 2026
- RTW INVESTMENTS, LP 2.31M sh · $73.93M · Q3 2026
- ORBIMED ADVISORS LLC 2.00M sh · $64.16M · Q3 2026
- Venrock Adviser, LLC 1.64M sh · $52.58M · Q3 2026
- EMERALD ADVISERS, LLC 1.61M sh · $51.67M · Q3 2026
- Siren, L.L.C. 1.61M sh · $51.53M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.57M sh · $50.42M · Q3 2026
More on Burkehill Global Management, LP
FAQ
How long has Burkehill Global Management, LP held COGT?
Burkehill Global Management, LP has disclosed COGT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Burkehill Global Management, LP's current position in COGT?
As of Q3 2026, Burkehill Global Management, LP holds 325.00K shares of COGT (COGENT BIOSCIENCES INC), valued at $10.41M, representing 0.45% of its reported portfolio and ranking #32.
Has Burkehill Global Management, LP been buying or selling COGT?
In the latest 13F filing (Q3 2026), Burkehill Global Management, LP held unchanged its position in COGT. The position peaked in Q1 2026 at 675.00K shares.
Which other funds hold COGT?
Other major institutional holders of COGT include DEERFIELD MANAGEMENT COMPANY, L.P., Fairmount Funds Management LLC, Kynam Capital Management, LP, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.